Dr. Katherine Marie Bell-Mcguinn MD Medical Oncologist

Dr. Katherine Bell-Mcguinn is a medical oncologist in New York, New York. She is affiliated with multiple hospitals in the area, including Bellevue Hospital Center and Memorial Sloan-Kettering Cancer Center. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice for 13 years. She is one of 34 doctors at Bellevue Hospital Center and one of 120 at Memorial Sloan-Kettering Cancer Center who specialize in Medical Oncology.

Are you Dr. Katherine Bell-Mcguinn? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Bellevue Hospital Center

Memorial Sloan-Kettering Cancer Center
Ranked #2 in Cancer

New York-Presbyterian Hospital
Ranked #22 in Cancer

Education & Medical Training

Johns Hopkins University
Residency, Internal Medicine, 2001 - 2004

Memorial Sloan-Kettering Cancer Center
Fellowship, Hematology/Oncology, 2004 - 2007

Johns Hopkins University School of Medicine
Class of 2001

Certifications & Licensure

American Board of Family Medicine
Certified in Family Medicine

American Board of Internal Medicine
Certified in Internal Medicine

WI State Medical License
Active through 2013

Publications & Presentations

Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
Barlin, J. N., Dao, F., Zgheib, N. B., Ferguson, S. E., Sabbatini, P. J., Hensley, M. L., Bell-McGuinn, K. M., Konner, J., Tew, W. P., Aghajanian, C., Chi, D. S.

Proceedings from the 9th International Conference on Ovarian Cancer.
Schmeler, K.M., Sood, A.K., Bell-McGuinn, K.M., Coleman, R.L., Frumovitz, M., Sonoda, Y., Ramirez, P.T., Gershenson, D.M., Barakat, R.R., Gardner, G.J.

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer.
Kaye, S.B., Lubinski, J., Matulonis, U., Ang, J.E., Gourley, C., Karlan, B.Y., Amnon, A., Bell-McGuinn, K.M., Chen, L., Friedlander, M., Safra, T., Vergote, I., Wickens, M., Lowe, E.S., Carmichael, J., Kaufman, B.

See all 13 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Coventry Florida - Employer Group PPO
  • First Choice
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • ODS Network
  • Premera BCBS Heritage & Heritage Plus 1
  • Providence Health System Personal Option
  • Regence Washington - Preferred Provider Network
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.